跳至主要内容
临床试验/ISRCTN11290592
ISRCTN11290592已完成3 期

Community pHarmaciEs Mood Intervention STudy (CHEMIST): Feasibility and Pilot Study

Tees, Esk and Wear Valleys NHS Foundation Trust0 个研究点目标入组 68 人开始时间: 2017年3月8日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
68

研究概览

简要总结

2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/31161045 protocol (added 05/06/2019) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35115052/ (added 15/02/2022) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35353469/ (added 26/04/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Adults (male or female, aged 18 years and over)
  • 2. One or more long-term conditions (Arthritis, Cancer, Cardiovascular Conditions, Diabetes, Respiratory Conditions, Stroke).
  • 3. Sub-threshold depression (screen positive with 2-4 symptoms confirmed by diagnostic assessment tool)

排除标准

  • Current participant exclusion criteria as of 04/04/2019:
  • 1. Alcohol or drug dependence
  • 2. Cognitive impairment
  • 3. Bipolar disorder or psychosis/psychotic symptoms
  • 4. Actively suicidal (ascertained by eligibility screening interviews)
  • 5. Currently in receipt of psychological therapy
  • Previous participant exclusion criteria:
  • 1. Alcohol or drug dependence
  • 2. Cognitive impairment
  • 3. Bipolar disorder or psychosis/psychotic symptoms
  • 4. Acutely suicidal (ascertained by eligibility screening interviews)
  • 5. Currently in receipt of psychological therapy

研究者

相似试验

Community pharmacies mood intervention study... | 临床试验